The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Preeclampsia: Pathophysiology, Diagnosis, and Management
Abstract
Preeclampsia, a major cause of fetal and maternal morbidity and mortality, may be difficult to distinguish clinically from other hypertensive disorders of pregnancy. Signs helpful in its diagnosis include presentation during late gestation in a nullipara with edema and proteinuria, and one or more of the following: hemoconcentration, hypoalbuminemia, liver function and/or coagulation abnormalities, and increased urate levels. Measures that may prove useful in differentiating preeclampsia from less dangerous forms of hypertension are decreased antithrombin III levels, increments in serum iron and carboxyhemoglobin, and decreases in urinary calcium. Major pathophysiological features of preeclampsia are decreased cardiac output, pulmonary capillary wedge pressure, and plasma volume; and marked increases in peripheral vascular resistance, as well as exaggerated pressor responses to endogenous angiotensin II and catecholamines. Renal hemodynamics decrease, in part as a result of a characteristic morphological lesion in glomeruli ("endotheliosis"), and there may be increased vascular permeability leading to albumin loss from the intravascular space. When gestation is advanced, termination is the treatment of choice; when temporization is required, several antihypertensive medications whose safety and efficacy have been tested in pregnant women are available. Magnesium sulfate remains the drug of choice for impending convulsions (the eclamptic phase of the disease). Finally, the etiology of preeclampsia remains unknown, but a popular theory suggests that alterations in prostaglandin metabolism may be responsible for the hypertension and coagulopathy in this disorder. In this respect, prophylactic treatment with low doses of aspirin, which decrease platelet thromboxane production but spare endothelial prostacyclin release, may decrease the incidence of preeclampsia in "high-risk" populations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar pattern is observed for VEGF, stimulating angiogenesis and promoting capillary permeability,29 leading to expansion of the interstitium.30, 31”
From Hypoalbuminemia: Pathogenesis and Clinical Significance (2019) · cites this paper as [31]
Citations
Cites
Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 949
Sibai, B. M., Taslimi, M. M., El-Nazer, A., Amon, E., Mabie, B. C., & Ryan, G. M. (1986) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(86)90266-8 · Cited by 596
PREVENTION OF PRE-ECLAMPSIA BY EARLY ANTIPLATELET THERAPY
Beaufils, M., Donsimoni, R., Uzan, S., & Colau, J. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92207-x · Cited by 470
The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases
Pritchard, J. A., Cunningham, F. G., & Pritchard, S. A. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90538-6 · Cited by 422
Fisher, K. A., Luger, A., Spargo, B. H., & Lindheimer, M. D. (1981) · Medicine · doi:10.1097/00005792-198107000-00002 · Cited by 374
Self-citationPreeclampsia is associated with a serum factor cytotoxic to human endothelial cells
Rodgers, G. M., Taylor, R. N., & Roberts, J. M. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(88)80169-8 · Cited by 278
Preeclampsia: a review of the role of prostaglandins.
Friedman, S. A. (1988) · PubMed · Cited by 255
PLACEBO-CONTROLLED TRIAL OF ATENOLOL IN TREATMENT OF PREGNANCY-ASSOCIATED HYPERTENSION
Rubin, P. C., Clark, D., Sumner, D., Low, R., Butters, L., Reynolds, B., Steedman, D. J., & Reid, J. L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91436-8 · Cited by 234
Taufield, P. A., Aleš, K. L., Resnick, L. M., Druzin, M. L., Gertner, J. M., & Laragh, J. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161204 · Cited by 212
The relationship between calcium intake and pregnancy-induced hypertension: Up-to-date evidence
Belizán, J. M., Villar, J., & Repke, J. T. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90091-9 · Cited by 208
Pregnancy outcome in 211 patients with mild chronic hypertension.
Sibai, B. M., Abdella, T. N., & Anderson, G. D. (1983) · PubMed · Cited by 205
Aarnoudse, J. G., Houthoff, H. J., Weits, J., Vellenga, E., & Huisjes, H. J. (1986) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07879.x · Cited by 138
Effect of Captopril on Uterine Blood Flow and Prostaglandin E Synthesis in the Pregnant Rabbit
Ferris, T. F., & Weir, E. K. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110834 · Cited by 134
Killam, A. P., Dillard, S. H., Patton, R. C., & Pederson, P. R. (1975) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(75)90856-x · Cited by 130
Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole
Wallenburg, H. C. S., & Rotmans, N. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80300-9 · Cited by 129
Thurnau, G. R., Kemp, D. B., & Jarvis, A. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(87)80239-9 · Cited by 120
Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester
Sibai, B. M., Taslimi, M. M., Abdella, T. N., Brooks, T. F., Spinnato, J. A., & Anderson, G. D. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(85)80171-x · Cited by 118
Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia
Clark, S. L., & Cotton, D. B. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90003-8 · Cited by 102
Plasma antithrombin III activity: An aid in the diagnosis of preeclampsia-eclampsia
Weiner, C. P., & Brandt, J. T. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90730-x · Cited by 100
Longitudinal evaluation of hemodynamic changes in eclampsia
Hankins, G. D. V., Wendel, G. D., Cunningham, F. G., & Leveno, K. J. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(84)90429-0 · Cited by 94
Lindheimer, M. D., & Katz, A. I. (1970) · New England Journal of Medicine · doi:10.1056/nejm197011122832008 · Cited by 92
Self-citationEarly onset pre-eclampsia: recognition of underlying renal disease.
Ihle, B. U., Long, P. A., & Oats, J. J. N. (1987) · BMJ · doi:10.1136/bmj.294.6564.79 · Cited by 80
The late postpartum eclampsia controversy.
Sibai, B. M., Schneider, J. M., Morrison, J. C., Lipshitz, J., Anderson, G. D., Shier, R. W., & DILTS, P. V. (1980) · PubMed · Cited by 75
Antithrombin III activity in women with hypertension during pregnancy.
Weiner, C. P., Kwaan, H. C., Xu, C., Paul, M. J., Burmeister, L. F., & Hauck, W. (1985) · PubMed · Cited by 71
Eclampsia II. Clinical significance of laboratory findings.
Sibai, B. M., Anderson, G. D., & McCubbin, J. H. (1982) · PubMed · Cited by 61
Antihypertensive Drugs in Pregnancy
Naden, R. P., & Redman, C. W. G. (1985) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30853-4 · Cited by 60
Mitogenic activity is increased in the sera of preeclamptic women before delivery
Musci, T. J., Roberts, J. M., Rodgers, G. M., & Taylor, R. N. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90572-8 · Cited by 58
Antibodies to laminin in preeclampsia
Foidart, J., Hunt, J., Lapière, C., Nusgens, B., Rycker, C. D., Bruwier, M., Lambotte, R., Bernard, A., & Mahieu, P. M. (1986) · Kidney International · doi:10.1038/ki.1986.106 · Cited by 57
Entman, S. S., Kambam, J. R., Bradley, C., & Cousar, J. B. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90134-7 · Cited by 57
Transcapillary fluid balance in pre‐eclampsia
ØIAN, P., MALTAU, J. M., NODDELAND, H., & FADNES, H. O. (1986) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07899.x · Cited by 52
Effect of low-dose aspirin on angiotensin II pressor response in human pregnancy
Sanchez‐Ramos, L., O’Sullivan, M. J., & Garrido-Calderon, J. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90236-5 · Cited by 49
Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia
Jouppila, P. I., Kirkinen, P. P., KOIVULA, A., & Ylikorkala, O. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90160-7 · Cited by 47
Watson, D. L., Sibai, B. M., SHAVER, D. C., Dacus, J. V., & Anderson, G. D. (1983) · Southern Medical Journal · doi:10.1097/00007611-198312000-00008 · Cited by 46
Zinaman, M. J., Rubin, J. M., & Lindheimer, M. D. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92314-1 · Cited by 45
Self-citationAntithrombin III Levels in Normotensive and Hypertensive Pregnancy
Weenink, G. H., Borm, J. J. J., Cate, T., & Treffers, P. E. (2010) · Gynecologic and Obstetric Investigation · doi:10.1159/000299264 · Cited by 38
Increased sensitivity to thromboplastin synthesis in blood monocytes from pre‐eclamptic patients
Øian, P., Omsjø, I. H., Maltau, J. M., & Østerud, B. (1985) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1985.tb01357.x · Cited by 32
Stirati, G., Manzi, M., Cardamone, I., & De Martino, A. (1983) · PubMed · Cited by 31
Persistent renal damage following pre‐eclampsia: A renal biopsy study of 13 patients
Heaton, J. M., & Turner, D. R. (1985) · The Journal of Pathology · doi:10.1002/path.1711470207 · Cited by 31
How Should Hypertension During Pregnancy Be Managed?: Experience at Parkland Memorial Hospital
Gunningham, F. G., & Pritchard, J. A. (1984) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31145-2 · Cited by 31
In utero aminoglycosides-induced nephrotoxicity in rat neonates
Mallié, J.-P., Coulon, G., Billerey, C., Faucourt, A., & Morin, J.-P. (1988) · Kidney International · doi:10.1038/ki.1988.6 · Cited by 27
Uterine and placental blood flow
Moawad, A. H., & Lindheimer, M. D. (1982) · Medical Entomology and Zoology · Cited by 26
Self-citationDe novo focal glomerular sclerosis in preeclampsia.
Nochy, D., Hinglais, N., Jacquot, C., Gaudry, C. L., Remy, P., & Bariety, J. (1986) · PubMed · Cited by 26
Focal glomerular sclerosis in pre-eclampsia.
Kida, H., Takeda, S., Yokoyama, H., Tomosugi, N., Abe, T., & Hattori, N. (1985) · PubMed · Cited by 22
Clinical applications of the altered iron kinetics of toxemia of pregnancy
Entman, S. S., & Richardson, L. D. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)90804-9 · Cited by 21
Konte, J., Holbrook, R., Laros, R. K., & Creasy, R. K. (1986) · American Journal of Perinatology · doi:10.1055/s-2007-999881 · Cited by 19
Early onset pre-eclampsia: recognition of underlying renal disease.
Lindheimer, M. D., & Chesley, L. C. (1987) · BMJ · doi:10.1136/bmj.294.6586.1547-b · Cited by 10
Self-citationSpitz, B., Magness, R. R., HANSSENS, M. C. A. J. A., Gant, N. F., & Assche, F. A. V. (1988) · Journal of Hypertension · doi:10.1097/00004872-198802000-00028 · Cited by 4
Cited by
Sorted by citations
Hypoalbuminemia: Pathogenesis and Clinical Significance
Soeters, P. B., Wolfe, R. R., & Shenkin, A. (2019) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1451 · Cited by 1,448
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
(1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90653-o · Cited by 441
Schwartz, R. B., Feske, S. K., Polak, J. F., Girolami, U. D., Iaia, A., Beckner, K. M., Bravo, S. M., Klufas, R. A., Chai, R. Y., & Jt, R. (2000) · Radiology · doi:10.1148/radiology.217.2.r00nv44371 · Cited by 388
Remuzzi, G., & Ruggenenti, P. (2012) · SpringerReference · doi:10.1007/springerreference_226547 · Cited by 267
Metadata
- Authors
- Lindheimer, M. D., & Katz, A. I.
- Affiliations
- University of Chicago (US)
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 1989-02
- Volume
- 40
- Issue
- 1
- Pages
- 233-250
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2115403364
- Cited by
- 128
- References
- 47
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 8 · 2017: 1 · 2016: 11 · 2015: 2 · 2014: 7 · 2013: 6 · 2012: 4
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annual Review of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-24498)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy-related medical research
- Keywords
- preeclampsia, hypertensive disorders of pregnancy, pathophysiology, proteinuria, endotheliosis, antithrombin III, magnesium sulfate, eclampsia, antihypertensive drugs in pregnancy, aspirin prophylaxis, prostaglandin metabolism, thrombocytopenia, systemic vascular resistance, abortion
- MeSH terms
- Antihypertensive Agents, Diagnosis, Differential, Eclampsia, Female, Hemodynamics, Humans, Magnesium Sulfate, Pre-Eclampsia, Pregnancy, Dinoprostone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review